HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas E Boyd Selected Research

Cisplatin (Platino)

1/2021A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas E Boyd Research Topics

Disease

4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2018 - 03/2007
3Neoplasms (Cancer)
01/2021 - 01/2013
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2018 - 06/2014
2Lymphoma (Lymphomas)
01/2021 - 04/2013
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 12/2016
2Thrombocytopenia (Thrombopenia)
01/2018 - 03/2007
2Neutropenia
12/2016 - 08/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2016 - 08/2014
1Pneumonia (Pneumonitis)
12/2016
1Colitis
12/2016
1Diarrhea
12/2016
1Exanthema (Rash)
12/2016
1Disease Progression
10/2016
1Hematologic Neoplasms (Hematological Malignancy)
06/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2013
1Opportunistic Infections (Opportunistic Infection)
03/2007
1Tumor Lysis Syndrome
03/2007
1Second Primary Neoplasms (Neoplasms, Second)
03/2007

Drug/Important Bio-Agent (IBA)

4Rituximab (Mabthera)FDA Link
01/2021 - 04/2013
3Bendamustine HydrochlorideFDA Link
01/2021 - 12/2016
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 08/2014
2Bevacizumab (Avastin)FDA Link
01/2021 - 08/2014
2idelalisibIBA
06/2018 - 12/2016
2Proteins (Proteins, Gene)FDA Link
02/2018 - 03/2007
2Azacitidine (5 Azacytidine)FDA Link
01/2018 - 06/2014
2oblimersen (G3139)IBA
11/2009 - 03/2007
2fludarabineIBA
11/2009 - 03/2007
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2009 - 03/2007
1Sunitinib (Sutent)FDA Link
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1SpermineIBA
01/2021
1ofatumumabFDA Link
01/2021
1PolyaminesIBA
01/2021
1GemcitabineFDA Link
01/2021
1Docetaxel (Taxotere)FDA Link
01/2021
1(N(1),N(12))bis(ethyl)- 6,7- dehydrospermineIBA
01/2021
1Fluorouracil (Carac)FDA LinkGeneric
01/2021
1Lenalidomide (CC 5013)FDA Link
02/2018
1ACE-011IBA
02/2018
1HematinicsIBA
02/2018
1Activin Receptors (Activin Receptor)IBA
02/2018
1cc-486IBA
01/2018
1Transaminases (Aminotransferases)IBA
12/2016
1LY2603618IBA
10/2016
1Pemetrexed (MTA)FDA Link
10/2016
1Toll-Like Receptor 9IBA
08/2014
1PlatinumIBA
08/2014
1IMO-2055IBA
08/2014
1ElectrolytesIBA
08/2014
1VorinostatFDA Link
04/2013
1Carboplatin (JM8)FDA LinkGeneric
04/2013
1Etoposide (VP 16)FDA LinkGeneric
04/2013
1IceIBA
04/2013
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2013
1ibrutinibIBA
01/2013
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2013
1Phosphotransferases (Kinase)IBA
01/2013
1CytokinesIBA
03/2007

Therapy/Procedure

3Therapeutics
01/2021 - 08/2014
3Drug Therapy (Chemotherapy)
08/2014 - 03/2007